trending Market Intelligence /marketintelligence/en/news-insights/trending/dzvmlbTlbYSKQ-IB6y205g2 content esgSubNav
In This List

Novelion Therapeutics appoints CFO

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints

Blog

Shore Capital is Now Available in S&P Global’s Aftermarket Research Collection


Novelion Therapeutics appoints CFO

Novelion Therapeutics Inc. appointed Michael Price as CFO and senior vice president, effective Dec. 4.

Price joins Novelion from Noven Pharmaceuticals Inc., where he served as vice president and CFO.

Gregory Perry has resigned as CFO of Novelion to pursue other opportunities, and will remain with the company until Dec. 31 to enable an effective transition.